Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Lipid disorders in liver diseases].

P Studeník1

  • 1Centrum kardiovaskulární a transplantacní chirurgie, Brno.

Vnitrni Lekarstvi
|May 10, 2001
PubMed
Summary

Liver diseases impact lipid metabolism, altering cholesterol and triglyceride levels. While hypertriglyceridemia can cause liver steatosis, hypercholesterolemia does not.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Development of immunosuppressant treatment after liver transplant].

Vnitrni lekarstvi·2013
Same author

[Interventional radiology options to address certain complications of the orthotopic liver transplant].

Vnitrni lekarstvi·2013
Same author

[Treatment of hepatocellular carcinoma and current situation in the Czech Republic].

Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·2008
Same author

[Liver transplantation for hepatitis B].

Vnitrni lekarstvi·2005
Same author

[The role of liver transplantation in clinical practice].

Vnitrni lekarstvi·2005
Same author

[The results of kidney transplantation from very young paediatric cadaveric donors to adult recipients in Czech Republic in the years 1994-2001 (retrospective study of the Czech transplant centres)].

Sbornik lekarsky·2004

Area of Science:

  • Biochemistry
  • Hepatology
  • Lipidology

Context:

  • The liver plays a central role in metabolizing cholesterol, triglycerides, and synthesizing lipoproteins.
  • Liver diseases, such as cirrhosis and cholestasis, significantly alter lipid profiles.
  • Primary lipid disorders can precipitate liver conditions like steatosis.

Purpose:

  • To elucidate the complex relationship between liver function, lipid metabolism, and various liver diseases.
  • To differentiate the lipid changes observed in parenchymatous versus cholestatic liver conditions.
  • To identify key risk factors contributing to the development of liver steatosis.

Summary:

  • Diffuse parenchymatous liver diseases, including cirrhosis, lead to decreased very-low-density lipoprotein (VLDL) and high-density lipoprotein (HDL) particles, along with reduced apo-B and apo-E.
  • Cholestatic liver diseases are characterized by elevated free cholesterol and phospholipids, with a subsequent decline in terminal stages. Lipoprotein X is a specific marker for cholestasis.
  • Hypertriglyceridemia is identified as a primary risk factor for liver steatosis, driven by increased fatty acid supply to the liver and impaired VLDL synthesis/triglyceride release. Hypercholesterolemia is not a risk factor.

Impact:

  • Provides a comprehensive overview of how liver diseases affect systemic lipid metabolism.
  • Clarifies the distinct lipoprotein signatures associated with different types of liver pathology.
  • Highlights the etiological role of hypertriglyceridemia in liver steatosis, guiding clinical and research focus.

Related Experiment Videos